Document is current

Any future updates will be listed below

Dupilumab additiv zur Triple-Therapie reduziert Exazerbationen

Crossref DOI link: https://doi.org/10.1007/s15033-023-3579-0

Published Online: 2023-10-25

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark